Neutron diffraction studies towards deciphering the protonation state of catalytic residues in the bacterial KDN9P phosphatase by Bryan, Tyrel et al.
crystallization communications
Acta Cryst. (2013). F69, 1015–1019 doi:10.1107/S1744309113021386 1015
Acta Crystallographica Section F
Structural Biology
and Crystallization
Communications
ISSN 1744-3091
Neutron diffraction studies towards deciphering the
protonation state of catalytic residues in the
bacterial KDN9P phosphatase
Tyrel Bryan,a‡ Javier M.
Gonza´lez,b‡ John P. Bacik,b
Nicholas J. DeNunzio,c
Clifford J. Unkefer,b Tobias E.
Schrader,d Andreas Ostermann,e
Debra Dunaway-Mariano,a
Karen N. Allenc and S. Zoe¨
Fisherb*
aDepartment of Chemistry and Chemical
Biology, University of New Mexico,
Albuquerque, NM 87131, USA, bBioScience
Division B-11, Los Alamos National Laboratory,
PO Box 1663, Los Alamos, NM 87545, USA,
cDepartment of Chemistry, Boston University,
590 Commonwealth Avenue, Boston,
MA 02115, USA, dJu¨lich Centre for Neutron
Science (JCNS) at Heinz Maier-Leibnitz Zentrum
(MLZ), Forschungszentrum Ju¨lich GmbH,
Lichtenbergstrasse 1, 85748 Garching,
Germany, and eHeinz Maier-Leibnitz Zentrum
(MLZ), Technische Universita¨t Mu¨nchen,
Lichtenbergstrasse 1, 85748 Garching, Germany
‡ These authors contributed equally to this
manuscript.
Correspondence e-mail: zfisher@lanl.gov
Received 1 July 2013
Accepted 31 July 2013
The enzyme 2-keto-3-deoxy-9-O-phosphonononic acid phosphatase (KDN9P
phosphatase) functions in the pathway for the production of 2-keto-3-deoxy-
d-glycero-d-galacto-nononic acid, a sialic acid that is important for the survival
of commensal bacteria in the human intestine. The enzyme is a member of
the haloalkanoate dehalogenase superfamily and represents a good model for
the active-site protonation state of family members. Crystals of approximate
dimensions 1.5  1.0  1.0 mm were obtained in space group P21212, with unit-
cell parameters a = 83.1, b = 108.9, c = 75.7 A˚. A complete neutron data set was
collected from a medium-sized H/D-exchanged crystal at BIODIFFat the Heinz
Maier-Leibnitz Zentrum (MLZ), Garching, Germany in 18 d. Initial refinement
to 2.3 A˚ resolution using only neutron data showed significant density for
catalytically important residues.
1. Introduction
The haloalkanoate dehalogenase superfamily of enzymes (HADSF)
is represented in the proteomes of organisms from all three domains
of life, wherein its members participate in numerous diverse biolo-
gical processes (Collet et al., 1998; Koonin & Tatusov, 1994). The
superfamily is largely made up of phosphatases (Allen & Dunaway-
Mariano, 2004), which conserve a Rossmann-fold catalytic domain
consisting of a three-layered / sandwich of repeating – units. The
accessorizing of the core Rossmann domain with inserted domains or
segments has allowed diversification towards substrates and provides
a natural division of the HADSF into three major structural classes
(C0, C1 and C2) based on the location and topology of the insert
(Burroughs et al., 2006). HADSF phosphatase biochemical functions
have been invented and reinvented across these structural classes
(Burroughs et al., 2006). One critical function taken on by the
HADSF is in the synthesis of polyhydroxylated -keto acids that are
integrated into glycoproteins and glycolipids for cell-surface display
in prokaryotes and eukaryotes (Angata & Varki, 2002). A rare but
important polyhydroxylated -keto acid, 2-keto-3-deoxy-d-glycero-
d-galacto-nononic acid (KDN), is formed through the action of a
phosphatase, 2-keto-3-deoxy-9-O-phosphonononic acid phosphatase
(KDN9PP), which is a prototypical member of the YbrI clade of the
HADSF C0 subfamily (Burroughs et al., 2006). The presence of the
KDN unit on the bacterial outer cell membrane enables mimicry of
the human epithelial cell polysialic acid to aid in survival and foraging
of commensal bacteria within the intestine (Coyne & Comstock,
2008).
In the YbrI clade, the biological unit is comprised of four identical
Rossmann-fold core subunits that oligomerize via a central -barrel
domain formed from the inserts from each subunit such that residues
from the adjacent Rossmann domain contribute to the active site of
the neighboring subunit (with four active sites per tetramer; Parsons
et al., 2002). Substrates bind through the phosphoryl group at the
Rossmann core domain, with the substrate leaving group forming
interactions with the adjacent subunit. The core-domain catalytic
scaffold is formed by four loops (Fig. 1) that contribute one or more
amino-acid side chains to participate in binding the substrate phos-
phoryl group and/or the Mg2+ ion (Wang et al., 2008; Lu et al., 2009).
Loop 1 positions the Asp nucleophile (Asp10 in KDN9PP) and the
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Asp acid/base catalyst (Asp12). Both aspartate residues also bind the
Mg2+ cofactor via the Asp10 nucleophile carboxylate group and the
Asp12 backbone C O. The substrate phosphoryl group coordinates
to the Mg2+ cofactor and engages in hydrogen-bond interactions with
the side chains of the conserved Ser/Thr of Loop 2 (Thr54) and Lys of
Loop 3 (Lys80). Loop 4 provides a coordination bond from Asp103,
increasing the affinity for Mg2+. Through the use of this scaffold,
phosphoryl transfer is catalyzed in two partial reactions: phosphoryl
transfer from the substrate to the Asp nucleophile and phosphoryl
transfer from the aspartylphosphate intermediate to a water molecule
(Baker et al., 1998). The aspartate general acid/base residue functions
to protonate the substrate leaving group in the first partial reaction
and to deprotonate the water nucleophile in the second partial
reaction (Lahiri et al., 2002).
Despite the availability of high-resolution X-ray crystal structures
of KDN9PP, there are still many unknowns regarding the active-site
protonation and the catalytic mechanism of this diverse class of
enzymes. Knowledge of the protonation states of the conserved
catalytic residues and hydrogen-bonding interactions in the active
site will allow in-depth understanding of the mechanistic strategy
used by the HADSF in catalyzing the formation and hydrolysis of
the aspartylphosphate intermediate. Although the general acid/base
aspartate residue is hypothesized to be the proton donor to the
substrate leaving group, in most HADSF phosphatases this residue is
thought to form a hydrogen bond to a positively charged residue such
as Lys30 (Fig. 1b; Lu et al., 2005). The optimal pH for catalysis in
HADSF phosphatases typically falls in the pH 6.0–7.0 range. The
aspartate general acid/base may be protonated in the unliganded
form of the enzyme (its pKa may be perturbed upwards from that
of aspartate in solution), or it may be that the active form of the
substrate is singly protonated (the second pKa of -glucose-6-phos-
phate is 6.2; Knight et al., 1986) and that upon binding the proton
transfers from the substrate phosphate group to the aspartate.
As a representative of the HADSF, KDN9PP is a candidate for
neutron studies (i) because of the availability of high-resolution
(1.1 A˚) X-ray crystal structures of apo and transition-state analog
complexes (Wang et al., 2008; Lu et al., 2009), (ii) because it uses
oligomerization to close the active site and thus does not occur in
open and closed forms caused by domain–domain movement that
could complicate analysis and (iii) because it is amenable to crys-
tallization at a range of pH values (pH 5.5–8.5), enabling studies of
the protonation states of active-site residues and estimation of their
pKa (Wang et al., 2008).
The position of hydrogen is essential to the understanding of
catalysis, protein folding, ligand/drug/substrate binding and protein
engineering (Blakeley et al., 2008), yet it must often be surmised
from indirect evidence. X-rays scatter from electron clouds with an
increase in the magnitude of scattering occurring as a function of
atomic number Z; thus, there is little to no information on H atoms. In
contrast, neutrons scatter from atomic nuclei and scattering is similar
in magnitude for all elements, making the assignment of H (or D)
atom locations at medium resolution possible (Meilleur et al., 2006;
Blakeley et al., 2008; Yokoyama et al., 2012). A common strategy to
overcome the negative scattering and large incoherent cross-section
of H in neutron diffraction is H/D exchange. This dramatically
improves the signal-to-noise ratio; therefore, H/D exchange is
routinely used for crystal preparation prior to data collection (Chen
et al., 2012; Fisher, Kovalevsky, Domsic, Mustyakimov, McKenna
et al., 2010). A great deal of information can be extracted from a
neutron crystal structure of H/D-exchanged samples, such as solvent
accessibility, levels of H/D exchange, thermal fluctuations and iden-
tification of minimal folding domains in proteins (Bennett et al., 2008;
Fisher, Kovalevsky, Domsic, Mustyakimov, Silverman et al. 2010;
Yokoyama et al., 2012). Compared with the spherical solvent peaks
in electron-density maps, the shape of solvent nuclear density maps
makes it possible to differentiate between OH, H3O
+ and H2O (or
OD, D3O
+ and D2O) species (Kovalevsky et al., 2011; Cuypers et al.,
2013). Similarly, H/D atoms on amino-acid side chains are visible and
help to determine their protonation status and hydrogen-bonding
interactions (Fisher et al., 2011; Kovalevsky, Fisher et al., 2010;
Kovalevsky, Hanson et al., 2010; Ahmed et al., 2007). X-ray and
neutron diffraction data are highly complementary and can be
combined during model refinement in a joint approach. This leads
to more accurate structures and is the only approach that can give
direct atomic information on H/D-atom positions to guide enzyme
mechanistic studies (Adams et al., 2009; Afonine et al., 2010).
To gain insight into the KDN9PP active-site structure and catalytic
mechanism, we initiated joint X-ray and neutron diffraction studies
of H/D-exchanged KDN9PP at the Protein Crystallography Station
crystallization communications
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Table 1
Room-temperature neutron data-collection statistics.
Values in parentheses are for the highest resolution shell. The X-ray data shown are from
a hydrogenous crystal.
BIODIFF
neutron data
In-house
X-ray data
No. of images 201 180
Wavelength (A˚) 2.66 1.54
Space group P21212 P21212
Unit-cell parameters (A˚, ) a = 83.1, b = 108.9,
c = 75.7,
 =  =  = 90.0
a = 82.7, b = 108.9,
c = 75.6,
 =  =  = 90.0
Unit-cell volume (A˚3) 685570 682339
Resolution (A˚) 44.0–2.30 (2.37–2.30) 36.3–1.78 (1.81–1.78)
No. of reflections (total/unique) 56137/28420 (1796) 463685/66613 (3697)
Multiplicity 2.0 (1.4) 7.0 (6.6)
Mean I/(I) 4.6 (1.1) 14.5 (3.4)
Rmerge† (%) 0.14 (0.520) 0.070 (0.554)
Rp.i.m.‡ (%) 0.11 (0.478) 0.029 (0.232)
Completeness (%) 91.4 (70.6) 99.9 (98.3)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rp.i.m. =
P
hklf1=½NðhklÞ 
1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
Figure 1
Active site of the KDN9PP–Mg2+–VO3
–neuramic acid complex with the ligands
and catalytic residues shown in stick representation and the Mg2+ cofactor shown as
a magenta sphere. The X-ray coordinates are from Lu et al. (2009).
(PCS) at Los Alamos Neutron Science Center. Crystal preparation
and feasibility studies were carried out at the PCS and support
laboratories. The full data set reported here (Table 1) was collected
on the BIODIFF instrument at the FRM II research reactor in
Germany. Here, we report the crystal preparation and data collection
for the first neutron diffraction experiment on a HADSF member,
KDN9PP.
2. Experimental
2.1. Protein expression, purification and crystallization of KDN9PP
for neutron studies
Recombinant wild-type KDN9PP was isolated from transformed
and induced Escherichia coli cells and purified to homogeneity as
described previously (Wang et al., 2008) with the following modifi-
cations. Notably, a tenfold increase in yield was obtained by the use
of Terrific Broth plus glycerol with growth to high OD600 before
induction, as described below. Also, optimization of the flow rates
used for the hydrophobic affinity column led to improved purification
of the protein. E. coli BL21 (DE3) pLysS cells were transformed with
recombinant KDN9PP pET-3a plasmid. The transformed cells were
grown at 310 K with agitation at 250 rev min1 in Terrific Broth (Life
Technologies) containing 4 ml glycerol per litre of TB and 50 mg ml1
ampicillin for 4–6 h to an OD600 of 0.6–1.0. At this stage, protein
expression was induced overnight at 290 K with 0.4 mM isopropyl
-d-1-thiogalactopyranoside. The cells were harvested by centrifu-
gation (6500 rev min1) for 10 min at 277 K to yield 10 g of wet cells
per litre of culture medium. The cell pellet (40 g) was suspended
in 400 ml ice-cold buffer A (50 mM Na HEPES pH 7.5) and lysed
using a French press. The cell lysate was centrifuged at 277 K for
20 min at 20 000 rev min1. The supernatant protein was fractioned
by ammonium sulfate-induced precipitation. The 50–90%(w/v)
ammonium sulfate fraction was collected by centrifugation at
20 000 rev min1 for 15 min. The pellet was dissolved in 30 ml buffer
B [50 mM Na HEPES, 16%(w/v) ammonium sulfate pH 7.5]. The
resuspended protein was loaded onto a 10  300 mm BS Sepharose
column (GE Life Sciences) pre-equilibrated with buffer B at 277 K.
The column was washed with 5 CV (column volumes) of buffer B
and the protein was eluted with a linear gradient (10 CV) of 100–0%
buffer B (16–0% ammonium sulfate). The column fractions were
analyzed by SDS–PAGE. The desired protein fractions (90–100%
buffer A) were collected and concentrated using 10 kDa molecular-
weight cutoff Amicon Ultra centrifugal filters. The protein sample
was then subjected to buffer exchange using a HiPrep 16/60 Sepha-
cryl S-200 column equilibrated with 10 mM Na HEPES pH 7.0. The
protein was >99% pure as judged by SDS–PAGE analysis and the
total yield was 25 mg protein per gram of wet cells.
Purified KDN9PP was concentrated to 20 mg ml1 prior to crys-
tallization. Screening conditions were based on those previously
published (Lu et al., 2009) and refined to 0.1M Tris–HCl pH 8.5,
0.2M sodium acetate, 10 mM MgCl2, 30%(w/v) PEG 4000 (Fig. 2).
We first optimized the crystal-growth conditions in 24-well Linbro
plates using both hanging and sitting drops. Drop sizes ranged from
10 to 40 ml. Once these conditions had been optimized, we used
crystals from these drops to macroseed much larger drops (100–
200 ml). For the large-drop setups, we used the Sandwich Box from
Hampton Research. The crystallization drops were set up in the nine-
well glass plate and were allowed to undergo vapor diffusion against
25 ml well solution. Several large single crystals (1.0–1.5 mm in any
one dimension) deemed to be suitable for neutron diffraction studies
were selected and mounted in thick-walled quartz capillaries (0.4 mm
thickness Vitrotubes from Vitrocom). Once mounted, the crystals
were wicked dry and a liquid plug of 150 ml perdeuterated well
solution [0.1M Tris–HCl, 0.2M sodium acetate, 10 mM MgCl2,
30%(w/v) PEG 4K in 99.9% pure D2O] was introduced on either side
of the crystal prior to sealing the capillary with beeswax. The crystals
were allowed to undergo vapor H/D exchange in the capillary for 1–2
weeks prior to neutron diffraction testing. The first series of tests
were conducted at the PCS instrument at LANSCE (Fig. 3a). The full
data collection reported here was completed at BIODIFF at FRM II,
Technische Universita¨t Mu¨nchen (TUM), Germany (Fig. 3b).
The crystals used for X-ray structure determination were grown
using the same conditions but with much smaller volumes and using
traditional 24-well plates. Specifically, the sitting-drop method was
employed using 10 ml protein solution and 10 ml reservoir solution to
give a 20 ml total drop size. Crystals appeared after only a few days
and were mounted in 1 mm thin-walled quartz capillaries containing a
plug of the deuterated buffer solution. Even though the H/D atoms
do not contribute significantly to the X-ray scattering, there may be
subtle chemical differences (hydrogen-bond lengths etc.) between
hydrogenous (all-H) and exchanged (H/D) samples and it is desirable
to keep the two data sets as isomorphous as possible. For the purpose
of initial data refinement and assessment we used an all-hydrogenous
crystal for room-temperature X-ray data collection. Crystallization,
X-ray data collection and processing for the H/D-exchanged crystal
are ongoing.
2.2. Room-temperature X-ray and neutron data collection and
reduction
Suitable H/D-exchanged crystals of KDN9PP were selected for
both room-temperature X-ray and neutron data collection. Neutron
diffraction quality and data-collection feasibility were determined
using the Protein Crystallography Station at LANSCE. Several 24 h
test exposures were collected. These images were processed with a
version of d*TREK that had been modified in-house for use with
wavelength-resolved Laue neutron data (Pflugrath, 1999; Langan &
Greene, 2004). Although these H/D-exchanged crystals did diffract,
they were not deemed to be suitable for full data collection (Fig. 3a).
This was most likely to be owing to the age of the samples. Subse-
quently, several fresh crystals were prepared, transported to
BIODIFF at the FRM II, TUM, Germany and shown to diffract well
enough to enable full data collection (Table 1; Fig. 3b).
Full neutron data collection was conducted at the monochromatic
diffractometer BIODIFF with a cylindrical neutron image-plate
crystallization communications
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Figure 2
Photograph of an H/D-exchanged large single KDN9PP crystal grown at pH 8.5
(dimensions of 1.5  1.0  1.0 mm).
detector (Niimura et al., 1994; Maatel, Voreppe, France). The
cylindrical area detector of BIODIFF provides a large coverage of
reciprocal space, thereby allowing a large number of Bragg reflec-
tions to be recorded simultaneously. The readout resolution of the
image-plate scanner was set to 250 mm. The data set was collected
at room temperature using a pyrolytic graphite monochromator
(PG002) set at a wavelength of 2.66 A˚. A total of 201 frames were
recorded with a rotation range of 0.3 per frame and an exposure time
of 120 min. The intensities of the reflections were integrated and
scaled with DENZO (v.1.96.2) and SCALEPACK (v.1.98.2) (Otwi-
nowski & Minor, 1997; Minor et al., 2006).
X-ray data were collected from a hydrogenous crystal at room
temperature using an in-house Rigaku MicroMax-007 high-flux home
source equipped with VariMax optics and an R-AXIS IV++ image
plate. The source used is a standard Cu rotating-anode generator
operated at 40 kV and 30 mA. The crystal-to-detector distance was
150 mm, with 1 oscillation steps and 2 min exposure per frame. Data
processing and integration was performed using MOSFLM (Leslie,
1992) and the data were scaled and merged using SCALA (Evans,
2006). The reflections were reindexed using SFTOOLS (B. Hazes,
unpublished work). The X-ray data were collected to 1.78 A˚ resolu-
tion from 180 frames. The data-set statistics are shown in Table 1. The
model, including metals and solvent, refined against the X-ray data
alone was used in the joint refinement. The starting model for the
X-ray refinement was PDB entry 3e8m (Lu et al., 2009). The mole-
cular graphics in Figs. 1 and 4 were generated in PyMOL (v.1.5.0.4;
Schro¨dinger LLC).
3. Results and discussion
Several large KDN9PP crystals were prepared that were 1.0–1.5 mm
in any one dimension. An H/D-exchanged KDN9PP crystal diffracted
neutrons to 2.3 A˚ resolution and the final data set was 91%
complete with an Rmerge of 14% overall (Table 1). The preliminary
neutron diffraction study of KDN9PP reported here is the first for an
HADSF phosphatase and many of the results can be generalized to
other HADSF phosphotransferases because of the conservation of
the catalytic scaffold across family members. The large crystal size
and the length of time that are required to acquire neutron data often
deter most structural biologists from using neutron diffraction. These
findings clearly demonstrate that it is feasible to obtain a complete
neutron data set from a medium-sized H/D-exchanged crystal in 18 d.
These data will reveal many important details about the KDN9PP
active site and the ionization states of specific residues, as well as the
hydrogen-bonding patterns in the active site that support catalysis.
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Figure 4
Representative nuclear density maps of His44 and Trp29 after rigid-body
refinement against neutron data only. The exchanged D atoms are shown in white;
2Fo  Fc nuclear density is shown as a blue mesh and is contoured at 1.
Figure 3
Representative neutron diffraction images collected from H/D-exchanged KDN9PP crystals. (a) Neutron Laue time-of-flight diffraction test image for KDN9PP collected at
the Protein Crystallography Station at LANL and (b) monochromatic neutron diffraction pattern collected at BIODIFF at FRM II.
After initial refinement using the neutron data alone, there was
significant density for catalytically important residues (Fig. 4).
Evidently His44 is protonated and fully H/D-exchanged, and the
exchanged D on the side chain of Trp29 is clearly visible. Joint
neutron and X-ray structure refinement is in progress using both
a modified version of CNS for neutrons (nCNS) and phenix.refine
(Adams et al., 2009; Afonine et al., 2010). Initial nuclear density maps
after only one round of joint rigid-body refinement already reveal
some of the details of protonation and hydrogen bonding in KDN9PP
(Fig. 4). Rwork and Rfree (using phenix.refine) are already at 23.5 and
26.3%, respectively. We expect these values to improve as refinement
continues and we will extend this analysis to other residues and
solvent molecules. Analysis of the neutron structure will involve the
detailed mapping of H atoms, water orientations and hydrogen
bonding and analysis of active-site residues. These results will also
guide planning for the next set of KDN9PP structures at a different
pH and/or in complex with transition-state analogues.
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